期刊文献+

灵芝多糖对Aβ_(25-35)诱导的PC12细胞损伤的保护性研究 被引量:4

Protective effect of ganoderma lucidum polysaccharide against-amyloid-induced neurotoxicity in PC12 cells
下载PDF
导出
摘要 目的观察灵芝多糖(GLP)对β-淀粉样蛋白(Aβ25-35)诱导的PC12细胞损伤的保护作用。方法将Aβ25-35或(和)不同浓度的GLP加入体外培养的PC12细胞中,用MTT检测PC12细胞活力的变化;以DCFH-DA来检测细胞内活性氧(ROS)水平的改变;通过Western Blotting来检测Bcl-2和Bax的表达水平。结果 Aβ25-35处理36h后的PC12细胞存活率仅为对照的60.7%,细胞内ROS水平上升到原来的222.7%,同时Bcl-2/Bax比值下降,为对照组的60.0%。经不同浓度的GLP预处理后,细胞存活率均显著提高,分别能达到69.7%,80.7%和88.3%(P<0.01);10g/ml GLP预处理PC12细胞24h后,细胞内ROS水平下降至正常组的160.6%,Bcl-2/Bax比值升高到93.6%,P值均<0.01。结论 GLP对Aβ25-35诱导的PC12细胞损伤有保护作用。 Abstract: Objective To observe the protection effects of ganoderma lucidum polysaccharide(GLP) on-amyloid(A) induced neurotoxieity in PC12 cells. Methods Neurotoxicity was induced by addition of Aβ25-35 into cultures of PC12 cells and different doses of GLPS were administrated 2h before addition of Aβ25-35 into PC12 cell cultures. Cell viability, ROS level and the expression of Bcl-2 and Bax were measured using MTF, DCFH-DA and western blotting, respectively. Results The percentage of viability of PC12 cells treated with AI325-35 for 36h was 60.7% of contrD1 group. In addition, treatment with Aβ25_35 increased cellular ROS level (222.7% of the control value)and reduced the ratio of Bel-2/Bax (60.0% of the control value). Pretreatment with single dose of GLP at 2,10, and 50μg/ml increased cell viability by 65% ,80.7% ,and 88.3% (P 〈 0.01 ), respectively. In parallel, treatment with GLP at 10 μg/ml ignificantly decreased the level of intracellular ROS( 160.6% of the control value)and moderated the ratio of Bcl-2/Bax (93.6% of the control value) ,all P value 〈0.01. Conclusion The results suggest that pretreatment of GLP protects PC12 cells against Aβ25-35 induced neurotoxicity.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2012年第7期633-635,共3页 Journal of Apoplexy and Nervous Diseases
关键词 阿尔茨海默氏病 PC12细胞 Β-淀粉样蛋白 灵芝多糖 Alzheimer' s disease PC12 cell β-Amyloid Ganoderma lucidum polysaeeharide
  • 相关文献

参考文献9

  • 1Marques SC, Oliveira CR, Outeiro TF, ,t al. Alzheimer disease : the quest to understand complexity[J]. J Alzheimers Dis,2010,21(2) : 373 - 383.
  • 2Armstrong RA. The molecular biology of senile plaques and neurofi- brillary tangles in Alzheimer disease[ J]. Folia Neuropathol,2009, 47(4) :289 -299.
  • 3Knopman DS. Current treatment of raild cognitive impairment and Alzheimer' s disease [ J ]. Curr Neural Neurosci Rep, 2006,6 ( 5 ) : 365 - 371.
  • 4向俊宇,徐安,夏懋,周婷婷,范国荣.灵芝多糖的研究进展[J].药学实践杂志,2010,28(4):241-244. 被引量:14
  • 5Cheung WM, Hui WS, Chu PW, et al. Ganoderma extract activates MAP kinases and induces the neuronal differentiation of rat pheochro- mocytoma PC12 cells [ J 1. FEBS Lett,2000,486 ( 3 ) :291 - 296.
  • 6McDaid DG, Kim EM, Reid RE, et al. Parenteral antioxidant treat- ment preserves temporal discrimination following intrahippocampal aggregated Abeta( 1-42 ) injections [ J ]. Behav Pharmacol, 2005,16 (4) :237 -242.
  • 7Cao X, Wei Z, Gabriel GG, et al. Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures:implications for Alzheimer disease-related pathology [ J ]. BMC Neurosci ,2007,8:73.
  • 8晏涛,陈世保,徐蕾,杨丽,陈龙菊.灵芝多糖对阿尔茨海默病大鼠学习记忆和氧化应激的影响[J].陕西医学杂志,2011,40(4):387-389. 被引量:24
  • 9郭燕君,袁华,甘胜伟,黎莉.灵芝多糖对Aβ25-35诱导阿尔茨海默病模型大鼠脑组织的保护作用[J].中国组织化学与细胞化学杂志,2006,15(4):447-451. 被引量:10

二级参考文献40

  • 1胡斌杰,韩艳霞,姬红.正交实验法超声提取灵芝多糖最佳工艺研究[J].中药材,2008,31(1):142-143. 被引量:21
  • 2张维娟,刘彬,安玉会.灵草液对阿尔茨海默病模型大鼠脑组织氧化还原力的影响[J].陕西医学杂志,2004,33(7):591-594. 被引量:1
  • 3Yoon JS,Kim JM ,Lee H ,et al. Risperidone use in Koren patients with Alzheimer' sdisease: optimal dosage and effect on behaviourai and psychological symptoms, cognitive function and activities of daily living. Hum Psychopharmacal, 2003,18 (8) : 627.
  • 4Boveris AD, Galleano M, Puntarulo S. In vivo supplementation with Ginkgo biloba protects membranes against lipid peroxiclation. Phytother Res, 2007,21 (8): 735.
  • 5Zhu XL, Chen AF, Lin ZB. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol, 2007, 111 (2) : 219.
  • 6Mc-Daid DG, Kim EM, Reid RE, et al. Parenteral antioxidant treatment preserves temporal discrimination following intrahippoeampal aggregated A [beta] (1-42) injections[J]. Behavioural Pharmacology, 2005, 16 (4): 237.
  • 7Cao X, Wei Z, Gabriel GG, et al. Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in bippocampal cultures:implications for Alzheimer disease-related pathology. BMC Neurosci, 2007,8 : 73.
  • 8Esposito G, De-Filippis D, Maiuri MC, et al. Cannahidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta- amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci Lett, 2006. 399(1-2),91.
  • 9Walsh DM, Klyubin I, Fadeeva JV , et al . Naturally secreted oligomers of arnyloid beta protein potently inhibit hippoearnpal long-term potentiation in vivo. Nature, 2002, 416 (6680): 535-539
  • 10Schenk D, Barbour R, Dunn W. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 1999, 400 (6740): 173-177

共引文献42

同被引文献70

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部